SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-017989
Filing Date
2023-04-12
Accepted
2023-04-12 16:05:40
Documents
5
Period of Report
2023-05-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20007976x2_def14a.htm DEF 14A 542533
2 logo_seelostherapeutics.jpg GRAPHIC 35790
3 ny20007976x2_pc01.jpg GRAPHIC 742564
4 ny20007976x2_pc02.jpg GRAPHIC 788507
5 sig_rajmehra.jpg GRAPHIC 14562
  Complete submission text file 0001140361-23-017989.txt   2720645
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22245 | Film No.: 23815713
SIC: 2834 Pharmaceutical Preparations